Conference Call Scheduled for 4:30 pm Eastern Time on May 9th
NASDAQ, TSX: NVCN
VANCOUVER, May 3, 2019 /PRNewswire/ - Neovasc, Inc.
("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN), a leader
in the development of minimally invasive transcatheter mitral valve
replacement technologies and in the development of minimally
invasive devices for the treatment of refractory angina, today
announced that it will report financial results for the quarter
ended March 31, 2019 and host a
conference call and webcast at 4:30 pm
Eastern Time on Thursday, May 9, 2019.
Conference Call
& Webcast Thursday, May 9th @ 4:30 pm Eastern
Time
|
Domestic:
|
877-407-9208
|
International:
|
201-493-6784
|
Passcode:
|
13689510
|
Webcast:
|
http://public.viavid.com/index.php?id=133943
|
A replay of the event will be available via webcast through
August 9st on the
Company's website, www.neovasc.com, or at
http://public.viavid.com/index.php?id=133943.
About Neovasc Inc.
Neovasc is a
specialty medical device company that develops, manufactures and
markets products for the rapidly growing cardiovascular
marketplace. Its products include the Reducer, for the treatment of
refractory angina, which is not currently commercially available in
the United States and has been
commercially available in Europe
since 2015, and the Tiara™, for the transcatheter treatment of
mitral valve disease, which is currently under clinical
investigation in the United
States, Canada and
Europe. For more information,
visit: www.neovasc.com.
View original
content:http://www.prnewswire.com/news-releases/neovasc-to-announce-first-quarter-2019-financial-results-on-thursday-may-9th-300843366.html
SOURCE Neovasc Inc.